[go: up one dir, main page]

HUP9900313A1 - Antiösztrogének alkalmazása hím nemzőképesség szabályozására - Google Patents

Antiösztrogének alkalmazása hím nemzőképesség szabályozására

Info

Publication number
HUP9900313A1
HUP9900313A1 HU9900313A HUP9900313A HUP9900313A1 HU P9900313 A1 HUP9900313 A1 HU P9900313A1 HU 9900313 A HU9900313 A HU 9900313A HU P9900313 A HUP9900313 A HU P9900313A HU P9900313 A1 HUP9900313 A1 HU P9900313A1
Authority
HU
Hungary
Prior art keywords
compounds
oestrogens
steroid
receptor antagonists
estrogen receptor
Prior art date
Application number
HU9900313A
Other languages
English (en)
Inventor
Ursula-Friederike Habenicht
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of HUP9900313A1 publication Critical patent/HUP9900313A1/hu
Publication of HUP9900313A3 publication Critical patent/HUP9900313A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Junction Field-Effect Transistors (AREA)

Abstract

A jelen találmány tárgya antiösztrőgének alkalmazása hím nemzőképességszabályőzására használható gyógyszerkészítmény előállítására. Atalálmány értelmében antiösztrőgén hatású vegyületekként mind akőmpetitív antiösztrőgének (ösztrőgén-receptőr antagőnisták), mind azarőmatázgátlók szóba jönnek. A jelen találmány szerinti ösztrőgén-receptőr antagőnisták és arőmatázgátlók egyaránt lehetnekszterőidőkból levezetett vegyületek vagy nemszterőid vegyületek. Akészít- mények töbek között őrális adagőlásra alkalmas tablettákfőrmájában vagy nyújtőtt hatású alakban is előállíthatók. ŕ
HU9900313A 1995-03-16 1996-03-15 Use of anti-oestrogens as male contraceptives HUP9900313A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510862A DE19510862A1 (de) 1995-03-16 1995-03-16 Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle

Publications (2)

Publication Number Publication Date
HUP9900313A1 true HUP9900313A1 (hu) 1999-06-28
HUP9900313A3 HUP9900313A3 (en) 1999-11-29

Family

ID=7757669

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900313A HUP9900313A3 (en) 1995-03-16 1996-03-15 Use of anti-oestrogens as male contraceptives

Country Status (21)

Country Link
US (1) US20010056086A1 (hu)
EP (1) EP0814803B1 (hu)
JP (1) JPH11501648A (hu)
KR (1) KR19980703057A (hu)
CN (1) CN1151792C (hu)
AT (1) ATE342055T1 (hu)
CA (1) CA2215373A1 (hu)
CZ (1) CZ293771B6 (hu)
DE (2) DE19510862A1 (hu)
DK (1) DK0814803T3 (hu)
ES (1) ES2275273T3 (hu)
HU (1) HUP9900313A3 (hu)
IL (1) IL117515A (hu)
NO (1) NO974256L (hu)
NZ (1) NZ303672A (hu)
PL (1) PL186085B1 (hu)
PT (1) PT814803E (hu)
SK (1) SK284442B6 (hu)
TW (1) TW503106B (hu)
WO (1) WO1996028154A2 (hu)
ZA (1) ZA962176B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
EP2258375A1 (de) 2009-06-04 2010-12-08 Bayer Schering Pharma Aktiengesellschaft 17B-alkyl-17alpha-oxy-estratriene

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3213328A1 (de) * 1982-04-06 1983-10-06 Schering Ag 3,4,17-trioxygenierte 4,9(11)-androstadiene
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.

Also Published As

Publication number Publication date
DK0814803T3 (da) 2007-02-19
DE59611391D1 (de) 2006-11-23
AU713467B2 (en) 1999-12-02
CZ293771B6 (cs) 2004-07-14
AU5004696A (en) 1996-10-02
KR19980703057A (ko) 1998-09-05
SK284442B6 (sk) 2005-04-01
CN1178463A (zh) 1998-04-08
PT814803E (pt) 2007-02-28
CZ285297A3 (en) 1997-12-17
ES2275273T3 (es) 2007-06-01
HUP9900313A3 (en) 1999-11-29
NO974256L (no) 1997-11-14
CA2215373A1 (en) 1996-09-19
PL322253A1 (en) 1998-01-19
IL117515A (en) 2003-07-31
EP0814803B1 (de) 2006-10-11
SK123897A3 (en) 1998-02-04
WO1996028154A2 (de) 1996-09-19
TW503106B (en) 2002-09-21
IL117515A0 (en) 1996-07-23
MX9707008A (es) 1997-11-29
DE19510862A1 (de) 1996-09-19
NZ303672A (en) 2000-07-28
JPH11501648A (ja) 1999-02-09
CN1151792C (zh) 2004-06-02
ZA962176B (en) 1996-07-29
EP0814803A2 (de) 1998-01-07
NO974256D0 (no) 1997-09-15
WO1996028154A3 (de) 1997-05-01
US20010056086A1 (en) 2001-12-27
ATE342055T1 (de) 2006-11-15
PL186085B1 (pl) 2003-10-31

Similar Documents

Publication Publication Date Title
ATE427103T1 (de) Orale verabreichung von adenosin analogen
NO20014859L (no) Raskt dispergerbare doseringsformer inneholdende fiskegelatin
DE69615704D1 (de) Bioadhesive feste arzneimittelform
NO20073429L (no) Anvendelse av et antistoff mot interleukin-6-reseptor for fremstilling av et farmasoytisk preparat
KR920700630A (ko) 발현-촉진/증강된 해열성반응
BR9509478A (pt) Antagonistas da progesterona competitivos para o controle de fertilidade feminina orientada de acordo com a necessidade
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
HUP9900313A1 (hu) Antiösztrogének alkalmazása hím nemzőképesség szabályozására
KR870002845A (ko) 식욕조절 및 위암억제용 조성물
MD970244A (en) Dimer lysozime new application
ES2110258T3 (es) Derivados de 1,3,5(10)-estratrieno activos por via oral.
BRPI0415322A (pt) composição farmacêutica antiretroviral, processo para a preparação de uma composição farmacêutica antiretroviral, método para reduzir a carga de consumo de pìlulas para um paciente, método para aumentar a meia-vida in vivo de lamivudina e de zidovudina enquanto não afetando a meia-vida de nevirapina
HUP0004461A2 (hu) Apoliprotein B kiválasztást/mikroszomális trigliceridtranszfer-proteint gátló anyag alkalmazása gyógyászati készítmények előállítására és a fenti gyógyászati készítmények
HUP9802929A2 (hu) Allil-amin-származékok alkalmazása Helicobacter pylori fertőzés, valamint a fertőzéssel összefüggő betegségek kezelésére felhasználható gyógyszerkészítmények előállítására
ATE295169T1 (de) Arzneimittel gegen infertilität, die mit endometriose assoziiert ist
KR870010080A (ko) 면역촉진 활성을 갖는 트리펩티드
MX2024001230A (es) Anticoncepcion oral con progestageno solo.
Neto et al. lnitial experience with oxypyrantel in whipwonn infection
UA50814C2 (uk) Анальгетичний лікарський засіб
IT1265224B1 (it) Composizioni farmaceutiche per uso orale per il trattamento delle manifestazioni ulcerose gastro-duodenali ed esofagee